TDMS Study 97013-11 Pathology Tables
NTP EXP/TEST: 97013-11 WATER DISINFECTION MODEL (SODIUM BROMATE) PAGE: 1
TEST TYPE: SUBCHRON 26-WEEK INITIAL AND CURRENT BODY WEIGHT DATE: 06/18/04
ROUTE: SKIN APPLICATION TIME: 08:54:22
EIS REPORT 03
FACILITY: Battelle Columbus Laboratory
NTP C#: 97013B
CONTRACT NUMBER: N01-ES-65406
CAS NUMBER: 7789-38-0
ANIMAL SUPPLIER: TACONIC FARMS
CAGE RANGE: ALL
DATE RANGE: ALL
REASONS FOR REMOVAL: ALL
REMOVAL DATE RANGE: ALL
TREATMENT GROUPS: INCLUDE ALL
NTP EXP/TEST: 97013-11 WATER DISINFECTION MODEL (SODIUM BROMATE) PAGE: 2
TEST TYPE: SUBCHRON 26-WEEK INITIAL AND CURRENT BODY WEIGHT DATE: 06/18/04
ROUTE: SKIN APPLICATION EISRPT03 TIME: 08:54:22
----------------------------------------------------------------------------------------------------------------------------------
SPECIES-STRAIN: TG.AC HEMI-MICE SEX: FEMALE WEEK ON DOSE: 26 FIRST DOSE: 10/29/99
----------------------------------------------------------------------------------------------------------------------------------
-----INITIAL----- ------------CURRENT------------- -----CHANGE------
TREATMENT N MEAN(G) SD N MEAN(G) SD % REL CNTRL N MEAN(G) SD
0 MG/KG 15 19.4 1.4 11 27.1 5.5 11 7.6 4.6
64 MG/KG 15 19.4 1.4 10 27.6 3.2 101.8 10 8.4 2.4
128 MG/KG 15 19.5 1.1 11 25.7 3.5 94.8 11 6.3 3.7
256 MG/KG 15 19.3 1.2 11 28.2 3.3 104.0 11 8.6 2.7
TPA 15 19.6 1.0 0 0.0 0.0 0 0.0 0.0
----------------------------------------------------------------------------------------------------------------------------------
SPECIES-STRAIN: TG.AC HEMI-MICE SEX: MALE WEEK ON DOSE: 26 FIRST DOSE: 10/29/99
----------------------------------------------------------------------------------------------------------------------------------
-----INITIAL----- ------------CURRENT------------- -----CHANGE------
TREATMENT N MEAN(G) SD N MEAN(G) SD % REL CNTRL N MEAN(G) SD
0 MG/KG 15 24.2 2.2 12 34.5 6.2 12 10.2 4.0
64 MG/KG 15 23.4 2.0 11 34.2 3.4 99.1 11 10.5 2.9
128 MG/KG 15 24.2 1.7 13 34.6 3.7 100.2 13 10.5 2.9
256 MG/KG 15 23.8 1.8 15 30.5 3.5 88.4 15 6.7 3.2
TPA 15 24.6 1.7 0 0.0 0.0 0 0.0 0.0
-----------------------------------
---------- END-OF-REPORT ----------
-----------------------------------
